Koninklijke Philips | PHG - Assets


Koninklijke Philips reported EUR27.27B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Danaher USD 93.28B 914M Sep/2026
Demant DKK 40.03B 951M Jun/2026
Dexcom USD 6.24B 216.5M Sep/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Fresenius EUR 41.84B 526M Jun/2026
General Electric Aerospace USD 127.2B 477M Sep/2026
Getinge SEK 57.37B 6.55B Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
GN Store Nord DKK 29.55B 996M Jun/2026
Hitachi JPY 15.19T 146.32B Sep/2026
Idexx Laboratories USD 3.44B 56.84M Jun/2026
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Koninklijke Philips EUR 27.27B 4.38B Mar/2026
Medtronic USD 93.31B 278M Jun/2026
Philips EUR 26.7B 565M Jun/2026
ResMed USD 8.21B 754.14M Sep/2026
Smith & Nephew USD 11.01B 321M Jun/2026
Steris USD 10.74B 1.1M Jun/2026
Stryker USD 47.25B 683M Sep/2026
Teleflex USD 6.79B 3.78M Jun/2026
Terumo JPY 2.37T 61.86B Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026